Skip to content

Effect of tryptophan diet nursing on patients with metabolically related fatty liver disease

Effect of tryptophan diet nursing on patients with metabolically related fatty liver disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111307
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-05-07
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic-associated fatty liver disease

Interventions

Case group :None
Control group:None

Sponsors

Tangdu Hospital of the Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Case group: 1. Age >=18 years old; 2. Fatty liver is indicated by abdominal color Doppler ultrasound or CT; 3. Patients diagnosed with MAFLD according to the "Guidelines for the Prevention and Treatment of Metabolism-related (Non-Alcoholic) Fatty Liver Disease (2024 Edition)"; 4. Residents who have been residing in Xi 'an for a long time (more than one year); 5. I voluntarily participate in this research and agree to sign the informed consent form; 6. Be able to communicate normally with others and have good compliance at the same time; Control group: 1. The age is >=18 years old; 2. I voluntarily participate in this research and agree to sign the informed consent form; 3. Be able to communicate normally with others and have good compliance at the same time; 4. Those who meet the case exclusion criteria and have a history of fatty liver disease in the past are not included; 5. Matches were made based on the gender and age (+/-5 years old) of the cases, and those without imaging changes of fatty liver in the color Doppler ultrasound examination during the same period were selected; 6. No history of alcohol consumption or the amount of alcohol consumed converted to ethanol is less than 140g per week (less than 70g per week for women); 7. Have resided in Xi 'an for more than one year and be of Han ethnicity;

Exclusion criteria

Exclusion criteria: Case group: 1.Liver diseases caused by other reasons, such as hepatitis B or C, drug-induced liver diseases, genetic diseases, alcoholic liver diseases, etc; 2. Those with other major diseases (such as malignant tumors, severe heart diseases, kidney diseases, etc.); 3. Pregnant and lactating women; 4. Suffering from mental disorders; 5. Failure to cooperate with the collection of investigation information; 6. Have taken tryptophan supplements/multivitamin supplements in the past year; 7. Excessive alcohol consumption (ethanol intake =140g/w for men and >70g/w for women); 8. Those with missing dietary data; 9. Those who have changed their living habits in the past two months, including dietary habits, drinking habits, smoking habits, exercise habits and sleep habits; 10. Those with a history of cardiovascular diseases and cancer; 11. Those with a history of MAFLD. Control group: 1. Pregnant or lactating women; 2. There are patients with other serious diseases; 3. Those who do not cooperate with information collection; 4. Have taken tryptophan supplements/multivitamin supplements in the past year.

Design outcomes

Primary

MeasureTime frame
Tryptophan;

Countries

China

Contacts

Public ContactHeng Chunni

Tangdu Hospital of the Fourth Military Medical University

bingao0726@163.com+86 137 7210 0470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026